Misonix to Present at the 13th Annual Canaccord Genuity Musculoskeletal Conference on March 6
27 February 2018 - 11:30PM
Misonix, Inc. (Nasdaq:MSON) (“Misonix” or the “Company”), a
provider of minimally invasive therapeutic ultrasonic medical
devices that enhance clinical outcomes, today announced that it
will be participating in the Canaccord Genuity Musculoskeletal
Conference held at the Sheraton hotel in New Orleans, Louisiana on
Tuesday, March 6, 2018. Misonix President and Chief Executive
Officer, Stavros Vizirgianakis, will be making a company
presentation at 2:30 p.m. CT (3:30 p.m. ET) that day and will be
available to meet with institutional investors in one-on-one
meetings throughout the day.
The Misonix investor presentation is available
in the “Investor Relations” section of the Company’s website at
www.misonix.com. If you have questions about Misonix or are
interested in conducting a conference call or meeting with
management, please contact the Company’s investor relations firm,
JCIR, at (212) 835-8500 or via email at mson@jcir.com.
About Misonix, Inc.Misonix,
Inc. (Nasdaq:MSON) designs, develops, manufactures and markets
ultrasonic medical devices for the precise removal of hard and soft
tissue, including bone removal, wound debridement and ultrasonic
aspiration. Misonix is focused on leveraging its proprietary
ultrasonic technology to become the standard of care in operating
rooms and clinics around the world. Misonix's proprietary
ultrasonic medical devices are used in a growing number of medical
procedures, including spine surgery, neurosurgery, orthopedic
surgery, cosmetic surgery, laparoscopic surgery, and other surgical
and medical applications. At Misonix, Better Matters to us. That is
why throughout the Company’s 59-year history, Misonix has
maintained its commitment to medical technology innovation and the
development of ultrasonic surgical products that radically improve
patient outcomes. Additional information is available on the
Company's web site at www.misonix.com.
Contact: Joe Dwyer Chief
Financial OfficerMisonix, Inc.631-927-9113
Joseph Jaffoni, Norberto Aja, Jennifer NeumanJCIR212-835-8500 or
mson@jcir.com
Misonix (NASDAQ:MSON)
Historical Stock Chart
From Apr 2024 to May 2024
Misonix (NASDAQ:MSON)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Misonix Inc (NASDAQ): 0 recent articles
More News Articles